THO complex 4 pseudogene

THO complex 4 pseudogene (ENSG00000219039) is a genomic sequence related to the functional THO complex subunits but classified as a pseudogene, which means it is incapable of producing a functional protein product[2][5]. Pseudogenes are typically the result of gene duplication or retrotransposition events that acquire disabling mutations and can no longer encode a protein, though some may still be transcribed into RNA[5]. There is no evidence that this pseudogene produces a functional protein or is involved in disease pathways or therapeutic targeting. Key points: A pseudogene is a sequence with high homology to a functional gene but is not capable of giving rise to a functional protein product[2][5]. Pseudogenes, including THO complex 4 pseudogene, are not considered targets for drugs or biomarker development because they typically lack protein-coding function and have no direct therapeutic relevance[2][5]. While some pseudogenes have regulatory noncoding functions (e.g., acting as RNA decoys)[5], there is no evidence for this specific pseudogene having such a role or being involved in specific biological or disease processes. It belongs outside established categories for protein-coding therapeutic targets such as enzymes, receptors, ion channels, or transporters. If you are seeking information about the functional THO complex (not the pseudogene): The THO complex is a multisubunit protein complex involved in mRNA processing and export, but this pseudogene does not correspond to a functional component of that complex in humans[1][3]. Summary: THO complex 4 pseudogene is not a therapeutic target, is not considered a functional gene or receptor, and has no established clinical utility, pharmacology, or disease associations. Its entry as a "target" is likely a misclassification.